|
|
||||||||
Clinical Chemistry, Vol 30, 1182-1186, Copyright © 1984 by American Association for Clinical Chemistry
SB Rosalki and AY Foo
We describe two new methods for the separation and quantification of the bone and liver isoenzymes of alkaline phosphatase (EC 3.1.3.1) in plasma. In the first, we use wheat-germ lectin to precipitate the bone isoenzyme. About 80% of this, but minimal liver isoenzyme, is precipitated. The activity of the bone isoenzyme is calculated from measuring the alkaline phosphatase activity in the precipitate, that of liver alkaline phosphatase by subtracting the activity of the bone isoenzyme from total alkaline phosphatase activity. The liver fraction will also contain biliary, intestinal, and placental alkaline phosphatase if these are present in the original plasma, but correction for such activity is readily made. In the second method, samples are separated on cellulose acetate membranes that, before electrophoresis, have been soaked in buffer containing wheat-germ lectin. The bone isoenzyme is retarded and clearly separated from the liver fraction, allowing these isoenzymes to be quantified by densitometry. Both methods are rapid, reproducible, and suitable for use in the diagnostic laboratory.
The following articles in journals at HighWire Press have cited this article:
![]() |
R. Rej Clinical Chemistry through Clinical Chemistry: A Journal Timeline Clin. Chem., December 1, 2004; 50(12): 2415 - 2458. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Naylor, A. Rogers, R. B. Fraser, V. Hall, R. Eastell, and A. Blumsohn Serum Osteoprotegerin as a Determinant of Bone Metabolism in a Longitudinal Study of Human Pregnancy and Lactation J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5361 - 5365. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Broyles, R. G. Nielsen, E. M. Bussett, W. D. Lu, I. A. Mizrahi, P. A. Nunnelly, T. A. Ngo, J. Noell, R. H. Christenson, and B. C. Kress Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase Clin. Chem., October 1, 1998; 44(10): 2139 - 2147. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Price, T. P. Milligan, and C. Darte Direct comparison of performance characteristics of two immunoassays for bone isoform of alkaline phosphatase in serum Clin. Chem., November 1, 1997; 43(11): 2052 - 2057. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Guo, T. H. Jones, and R. Eastell Treatment of Isolated Hypogonadotropic Hypogonadism Effect on Bone Mineral Density and Bone Turnover J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 658 - 665. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Hoffmann, N. Everds, M. Pignatello, and P. F. Solter Automated and Semiautomated Analysis of Rat Alkaline Phosphatase Isoenzymes Toxicol Pathol, November 1, 1994; 22(6): 633 - 638. [Abstract] [PDF] |
||||
![]() |
M. H. Fischer, W. N. Adkins JR, B. H. Liebl, S. C. VanCalcar, and J. A. Marlett Bone Status in Nonambulant, Epileptic, Institutionalized Youth: Improvement with Vitamin D Therapy Clinical Pediatrics, October 1, 1988; 27(10): 499 - 505. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |